Molecular Signatures of TMS Response in Treatment-Resistant Depression
RecruitingNCT07039370Phase: NAStarted 2025-06-15
Summary
Transcranial Magnetic Stimulation (TMS) therapy is an approved and effective treatment option for treatment-resistant depression (TRD). This study aims to identify biomarkers that predict TMS treatmen
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Gulhane Training and Research HospitalAnkara, Ankara, Turkey (Türkiye)
Gulhane Training and Research HospitalAnkara, Ankara, Turkey (Türkiye)
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07039370